Alerting neurologists via telemedicine that a patient with suspected acute stroke is en route to the hospital significantly speeds thrombolytic treatment.
(DMAC) - DiaMedica Stock Gains On Green Signal To Start Pivotal DM199 Trial In Ischemic Stroke benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke - read this article along with other careers information, tips and advice on BioSpace